Regeneron (NASDAQ: REGN) is a leading biotechnology company that invents, develops and commercializes life-transforming medicines for people with serious diseases. Founded and led for over 35 years by physician-scientists, our unique ability to repeatedly and consistently translate science into medicine has led to numerous FDA-approved treatments and product candidates in development, almost all of which were homegrown in our laboratories. Our medicines and pipeline are designed to help patients with eye diseases, allergic and inflammatory diseases, cancer, cardiovascular and metabolic diseases, hematologic diseases, infectious diseases and rare diseases.
Shared 56 years ago
6.8K views
Shared 56 years ago
153K views
Shared 56 years ago
117K views
Shared 56 years ago
114K views
Shared 56 years ago
50 views
Shared 56 years ago
155 views
Shared 56 years ago
88 views
Shared 56 years ago
91 views
Shared 56 years ago
238 views
Shared 56 years ago
177 views
Shared 56 years ago
282 views
